Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
Tickers REGN SNY
Tags Recent Press Releases REGN SNY
From Motley Fool
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
Tickers ADM AMCR AMD AME
Tags INGR AME AZPN
From Benzinga
Regeneron Pharma Q4 Earnings Crush Estimates, Initiates Dividend And Additional Stock Buyback Program
Tickers NEWS REGN
Tags REGN Health Care Trading Ideas
From Benzinga
Earnings Scheduled For February 4, 2025
Tickers AAT ACT ADM AFG
Tags GOOG LARK EGHT
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Tickers ABT AKRO CVS LNTH
Tags TMO ABT MDT
From Benzinga
Beyond The Numbers: 18 Analysts Discuss Regeneron Pharmaceuticals Stock
Tickers REGN
Tags REGN Benzinga BZI/AAR
From Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags Trading Ideas BZI/SHORTHIST Market News
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Tickers NEWS REGN
Tags BZI/POD Market News Benzinga
From Benzinga
Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030
Tickers NEWS REGN
Tags Biotech Market News Briefs
From Benzinga
Forecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals
Tickers REGN
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Tickers AMGN BMY GILD LLY
Tags Analyst Ratings General Top Stories
From Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
Tickers REGN
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
Tickers REGN
Tags REGN Recent Press Releases Market News
From Motley Fool
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Tickers NEWS REGN
Tags REGN Benzinga News
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Tickers ABBV BMY ELAN GILD
Tags Benzinga Biotech ZTS
From Benzinga
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Tickers BAYRY NEWS REGN
Tags Health Care REGN Large Cap
From Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Tickers APA ASML AVGO CEG
Tags PFE REGN AVGO
From Benzinga
What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags REGN Benzinga Market News
From Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Tickers LB LLY NEWS NVTS
Tags LLY CNBC REGN
From Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
Tickers REGN
Tags BZI/UOA REGN Benzinga
From Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
Tickers REGN
Tags REGN Benzinga BZI/UOA
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags REGN Benzinga Short Sellers
From Benzinga
Check Out What Whales Are Doing With REGN
Tickers REGN
Tags Market News Markets Options
From Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Tickers NEWS REGN SNY
Tags Benzinga Top Stories General
From Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
2 Top Growth Stocks to Buy on the Dip
Tickers LLY REGN
Tags Market News REGN LLY
From Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Tickers AZN GSK NEWS REGN
Tags Top Stories Benzinga General
From Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
Tickers NEWS REGN
Tags Market News Markets BZI/IA
From Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Tickers ASML DELL IDXX MRNA
Tags ASML Market News Recent Press Releases
From Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Tickers AMGN AZN NEWS REGN
Tags AMGN Briefs Movers
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.